Funding for this research was provided by:
Cancerfonden (CAN 2016/548)
Fru Berta Kamprads Stiftelse (FBKS 2017/39)
Gyllenstiernska Krapperup Foundation (KR2018-0088)
Sir Albert Pålsson Foundation
Governmental Funding of Clinical Research within the National Health Service
Swedish Breast Cancer Association
Received: 25 December 2019
Accepted: 4 June 2020
First Online: 19 June 2020
Ethics approval and consent to participate
: The MDCS (LU 51-90) and the present study (Dnr 427/2007) were approved by the ethics committee in Lund, Sweden, and all study participants signed informed consent at enrollment.
: Not applicable.
: The authors declare that they have no competing interests. SB has received travel grants from Roche, honorary for advisory board and speaker’s fee from Pfizer.